Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wearable Biosensors for Early Detection of Malaria Following Controlled Human Malaria Infection
NCT07558122Phase 1Not yet recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Nov 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in malaria (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoints: Presence of detectable malaria parasitemia at Day 56, Time of detectable malaria parasitemia at Day 56 and 4 more. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
malaria
Beyond the preview
Go deeper on NCT07558122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07558122.